This week, the top managed care stories include Senator Bill Cassidy's new plan to lower healthcare costs; policy recommendations from the American Diabetes Association on how to lower insulin prices; and coverage from the American Society of Clinical Oncology annual meeting.
A Senator presents a new plan to lower healthcare costs, the American Diabetes Association offers recommendations to lower insulin prices, and AJMC® gets ready to cover ASCO.
Welcome to This Week in Managed Care, I’m Laura Joszt.
Cassidy's New Health Proposal
Price transparency would help lower healthcare costs, says Republican Senator Bill Cassidy of Louisiana. Cassidy offered a set of proposals this week that he said would bring down health insurance premiums. They include:
Cassidy also called for HHS to launch a study on the social determinants of health and disparities that currently affect the health system.
Recommendations for Insulin Access, Affordability
The American Diabetes Association has released a set of recommendations to make insulin more affordable, based on findings of a working group that were presented at a Senate hearing last month.
Insulin costs people with diabetes 15 billion dollars per year, and price increases are one reason the annual price tag for diabetes is now 327 billion dollars in the United States.
The policy statement makes four core recommendations:
ADA supports having HHS directly negotiate with drug companies for Medicare Part D—something that was not included in President Trump’s new prescription drug pricing plan.
ASCO Annual Meeting Coverage
This weekend the world of cancer care descends on Chicago, Illinois, for the annual meeting of the American Society of Clinical Oncology (ASCO). The American Journal of Managed Care® (AJMC®) will be there to bring you updates from the meeting, and you can already find previews of studies to be presented at ASCO, including:
Merck announced that new data to be presented at ASCO will bring more good news about pembrolizumab, the anti-PD-1 therapy sold as Keytruda.
The company said a new phase 3 study from the KEYNOTE trial has shown that the immunotherapy pembrolizumab and chemotherapy helped patients with advanced, squamous non-small cell lung cancer survive significantly longer than with chemotherapy alone.
Virginia to Pass Medicaid Expansion
Virginia appears poised to be the 33rd state to expand Medicaid, following votes from the Republican-controlled legislature. Governor Ralph Northam supports expansion, which will feature a work requirement that was not included in earlier attempts to expand the program.
The expansion plan is part of a broader budget agreement.
Emerging Leader Award
Do you know a young leader in managed care?
Early career investigators in healthcare and pharmacy are encouraged to apply for the Seema S. Sonnad Emerging Leader in Managed Care Research Award, which honors the late associate editor of The American Journal of Managed Care®.
For all of us at the Managed Markets News Network, I’m Laura Joszt. Thanks for joining us.